Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edition By Michelle J. Willihnganz, Samuel L. Gurevitz, Bruce Clayton All Chapters 1-48 LATEST

TestBankForClayton’sBasicPharmacologyforNurses19thEditionBy
fMichelleJ.Willihnganz,SamuelL.Gurevitz,BruceClaytonComplete
g

,Chapter 01: Drug Definitions, Standards, and Information Sources
fg fg fg fg fg fg fg


Willihnganz: Clayton’s Basic Pharmacology for Nurses, 19th Edition
fg fg fg fg fg fg fg fg




MULTIPLE CHOICE fg




Which name identifies a drug listed by the US Food and
fg fg fg fg fg fg fg fg fg fg


Drug Administration (FDA)?
fg fg fg


Brand
Nonproprietary
fg


Official
fg


Trademark
fg




ANS: C fg


The official name is the name under which a drug is
fg fg fg fg fg fg fg fg fg fg


listed by the FDA. The brand name, or trademark, is the
fg fg fg fg fg fg fg fg fg fg fg


name gi ven to a drug by its manufacturer. The
fg fg fg fg fg fg fg fg fg fg


nonproprietary, or g eneric, name is provided by the
fg fg fg fg fg fg fg fg fg


United States Adopted Na mes Council.
fg fg fg fg fg fg




DIF: Cognitive Level: Knowledge REF: p. 9 fg fg fg fg


OBJ: 1NAT: NCLEX Client Needs Category: Safe, Effective
fg fg fg fg fg fg fg


Care Environment TOP: Nursing Process Step: Assessment CON:
fg fg fg f g fg fg fg


Patient Education
fg fg




Which source contains information specific to nutritional supplements?
fg fg fg fg fg fg fg


USP Dictionary of USAN & International Drug Names
fg fg fg fg fg fg fg


Natural Medicines Comprehensive Database
fg fg fg fg


United States Pharmacopoeia/National Formulary (USP NF)
fg fg fg fg fg


Drug Interaction Facts
fg fg fg




ANS: C fg


United States Pharmacopoeia/National Formulary contains information specific to
fg fg fg fg fg fg fg


nutrition al supplements. USP Dictionary of USAN & International Drug Names is a
fg fg fg fg fg fg fg fg fg fg fg fg fg


compilation of d rug names, pronunciation guide, and possible future FDA approved
fg fg fg fg fg fg fg fg fg fg fg fg


drugs; it does not includ e nutritional supplements. Natural Medicines Comprehensive
fg fg fg fg fg f g fg fg fg fg fg


Database contains evidence- based information on herbal medicines and herbal
fg fg fg fg fg fg fg fg fg fg


combination products; it does not include information specific to nutritional supplements.
fg fg fg fg fg fg fg fg fg fg fg


Drug Interaction Facts contains comprehen sive information on drug interaction facts; it
fg fg fg fg fg fg fg fg fg fg fg fg


does not include nutritional supplements.
fg fg fg fg fg




DIF: Cognitive Level: Knowledge REF: p. 4 OBJ: 3 fg fg f g fg fg


NAT: NCLEX Client Needs Category: Physiological Integrity
fg fg fg fg fg fg


TOP: Nursing Process Step: Assessment
f g CON: Nutrition | Patient Education
fg fg fg fg fg fg fg




Which drug reference contains drug monographs that describe all drugs in a therapeutic
fg fg fg fg fg fg fg fg fg fg fg fg


cla ss? a. Drug Facts and Comparisons
fg fg fg fg fg fg fg

,TestABank For Clayton’s Basic Pharmacology for Nurses 19th Edition
fg fg fg fg fg fg fg fg 3

Drug Interaction Facts
fg fg


Handbook on Injectable
fg fg fg


Drugs
fg


Martindale—The Complete Drug Reference fg fg fg




ANS: A fg


Drug Facts and Comparisons contains drug monographs that describe all drugs
fg fg fg fg fg fg fg fg fg fg


in
fg a therapeutic class. Monographs are formatted as tables to allow
f g fg fg fg fg fg fg fg fg fg


comparison of si milar products, brand names, manufacturers, cost indices, and
fg fg fg fg fg fg fg fg fg fg fg


available dosage for ms Online version is available.
fg fg fg fg fg fg fg fg




DIF: Cognitive Level: Knowledge REF: p. 4 Table 1.2 fg fg fg fg fg fg


OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity fg fg fg fg fg fg


CON: Safety | Patient Education | Clinical fg fg fg fg fg fg

TOP: Nursing Process Step: Judgme nt fg fg fg fg

Assessment fg




Which drug reference contains monographs about virtually every single-
fg fg fg fg fg fg fg fg


entity drug available in the United States and describes therapeutic uses of drugs,
fg fg fg fg fg fg fg fg fg fg fg fg


includin g approved and unapproved uses?
fg f g fg fg fg fg


Martindale: The Complete Drug Reference fg fg fg fg


AHFS Drug Information
fg fg fg


Drug Reference fg


Drug Facts and Comparisons fg fg fg




ANS: B fg


AHFS Drug Information contains monographs about virtually every single-
fg fg fg fg fg fg fg fg


entity drug available in the United States and describes therapeutic uses of drugs, including
fg fg fg fg fg fg fg fg fg fg fg fg fg


approved and unapproved uses.
fg fg fg fg




DIF: Cognitive Level: Knowledge REF: p. 4 Table 1.2 fg fg fg fg fg fg


OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity fg fg fg fg fg fg


CON: Safety | Patient Education | Clinical fg fg fg fg fg fg


TOP: Nursing Process Step: Planning Judgme fg fg fg fg


nt

Which online drug reference makes available to healthcare providers and the public a
fg fg fg fg fg fg fg fg fg fg fg fg


stand ard, comprehensive, up-to-date look up and downloadable resource about
fg fg fg fg fg fg fg fg fg fg


medicines?
fg


American Drug Index fg fg


American Hospital Formulary
fg fg fg


DailyMed
fg


Drug Reference fg




ANS: C fg


DailyMed makes available to healthcare providers and the public a standard,
fg fg fg fg fg fg fg fg fg fg


comprehensiv e, up-to-
fg fg fg


date look up and downloadable resource about medicines. The American Drug Index is
fg fg fg fg fg fg fg fg fg fg fg fg


not appropriate for patient use. The American Hospital Formulary is not appropriate
fg fg fg fg fg fg fg fg fg fg fg fg


for patie nt use. The drug reference is not appropriate for patient use.
fg fg f g fg fg fg fg fg fg fg fg fg fg




DIF: Cognitive Level: Knowledge REF: p. 3 | p. 4 OBJ: 3 fg fg f g fg fg fg fg fg


NAT: NCLEX Client Needs Category: Physiological Integrity
fg fg fg fg fg fg


TOP: Nursing Process Step: Implementation
fg fg fg fg fg


CON: Safety | Patient Education | Clinical Judgment
fg fg fg fg fg fg fg




Which legislation authorizes the FDA to determine the safety of a drug before its marketing?
fg fg fg fg fg fg fg fg fg fg fg fg fg fg


Federal Food, Drug, and Cosmetic Act (1938)
fg fg fg fg fg fg


Durham Humphrey Amendment (1952)
fg fg fg fg

, TestABank For Clayton’s Basic Pharmacology for Nurses 19th Edition
fg fg fg fg fg fg fg fg 4

Controlled Substances Act (1970) fg fg fg


Kefauver Harris Drug Amendment
fg fg fg fg


(1962)
fg




ANS: A fg


The Federal Food, Drug, and Cosmetic Act of 1938 authorized the FDA to determine the
fg fg fg fg fg fg fg fg fg fg fg fg fg fg


sa fety of all drugs before marketing. Later amendments and acts helped tighten FDA
fg fg fg fg fg fg fg fg fg fg fg fg fg fg


control a nd ensure drug safety. The Durham Humphrey Amendment defines the kinds of
fg fg fg fg fg fg fg fg fg fg fg fg fg fg


drugs that cannot be used safely without medical supervision and restricts their sale
fg fg fg fg fg fg fg fg fg fg fg fg fg


to prescription by a licensed practitioner. The Controlled Substances Act addresses only
fg fg fg fg fg fg fg fg fg fg fg fg


controlled substances and their categorization. The Kefauver Harris Drug Amendment
fg fg fg fg fg fg fg fg fg fg


ensures drug efficacy and g reater drug safety. Drug manufacturers are required to
fg fg fg fg fg fg fg fg fg fg fg fg fg


prove to the FDA the effectiveness o f their products before marketing them.
fg fg fg fg fg fg fg fg fg fg fg fg fg




DIF: Cognitive Level: Knowledge REF: p. 5 Table l.3 fg fg f g fg fg fg


OBJ: 5 NAT: NCLEX Client Needs Category: Physiological Integrity
f g fg fg fg fg fg fg


TOP: Nursing Process Step: Assessment
fg fg fg fg


CON: Safety | Patient Education | Evidence | Health Care Law
fg fg fg fg fg fg fg fg fg fg




Which classification does meperidine (Demerol) fall under?
fg fg fg fg fg fg


I
I f g


I
II fg


I
I fg


V
ANS: B fg


Meperidine (Demerol) is a Schedule II drug; it has a high potential for abuse and may
fg fg fg fg fg fg fg fg fg fg fg fg fg fg fg


lead
fg to severe psychological and physical dependence. Schedule I drugs have high
f g fg fg fg fg fg fg fg fg fg fg


potential for abuse and no recognized medical use. Schedule III drugs have some
fg fg fg fg fg fg fg fg fg fg fg fg fg


potential for abuse. Us e may lead to low to moderate physical dependence or high
fg fg fg fg f g fg fg fg fg fg fg fg fg fg fg


psychological dependence. Sch edule IV drugs have low potential for abuse. Use may
fg fg fg fg fg fg fg fg fg fg fg fg fg


lead to limited physical or psycholog ical dependence.
fg fg fg fg fg fg fg fg




DIF: Cognitive Level: Knowledge REF: p. 10 OBJ: 2 fg fg f g fg fg


NAT: NCLEX Client Needs Category: Safe, Effective Care
fg fg fg fg fg fg fg fg


Environment
fg


TOP: Nursing Process Step: Assessment
f g CON: Patient Education | Addiction | Pain
fg fg fg fg fg fg fg fg fg




Which action would the FDA take to expedite drug development and approval for an
fg fg fg fg fg fg fg fg fg fg fg fg fg


outbr eak of smallpox?
fg fg fg fg


List smallpox as a health orphan disease.
fg fg fg fg fg fg


Omit the preclinical research phase.
fg fg fg fg fg


Extend the clinical research phase. fg fg fg fg


Fast track the investigational
fg fg fg fg


drug. fg




ANS: D fg


Once the Investigational New Drug Application has been approved, the drug can receive
fg fg fg fg fg fg fg fg fg fg fg fg


hi ghest priority within the agency, which is called fast tracking. A smallpox outbreak
fg fg fg fg fg fg fg fg fg fg fg fg fg fg


would become a priority concern in the world. Orphan diseases are not researched in a
fg fg fg fg fg fg fg fg fg fg fg fg fg fg fg


priority ma nner. Preclinical research is not omitted. Extending any phase of the
fg fg fg fg fg fg fg fg fg fg fg fg fg


research would mean a longer time to develop a vaccine. The FDA must ensure that
fg fg fg fg fg fg fg fg fg fg fg fg fg fg fg


all phases of the preclinical and clinical research phase have been completed in a safe
fg fg fg fg fg fg fg fg fg fg fg fg fg fg fg


manner.
fg




DIF: Cognitive Level: Knowledge fg fg REF: f g p. 7 fg OBJ: 5 fg